4//SEC Filing
KIDRON NADAV 4
Accession 0001213900-25-012239
CIK 0001176309other
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 4:31 PM ET
Size
9.2 KB
Accession
0001213900-25-012239
Insider Transaction Report
Form 4
KIDRON NADAV
DirectorPresident and CEO
Transactions
- Award
Common Stock
2025-02-11+141,000→ 2,400,598 total - Award
Common Stock
2025-02-11+186,000→ 2,586,598 total - Award
Common Stock
2025-02-11+100,000→ 2,686,598 total
Holdings
- 126,000(indirect: By wholly-owned corporation)
Common Stock
Footnotes (3)
- [F1]Represents shares issued on settlement of performance stock units ("PSUs") previously granted on January 4, 2024 that vested on February 11, 2025 based on the achievement of the applicable performance criteria.
- [F2]Represents shares issued on settlement of PSUs previously granted on January 2, 2025 that vested on February 11, 2025 based on the achievement of the applicable performance criteria.
- [F3]Represents shares issued on settlement of PSUs previously granted on February 3, 2025 that vested on February 11, 2025 based on the achievement of the applicable performance criteria.
Documents
Issuer
ORAMED PHARMACEUTICALS INC.
CIK 0001176309
Entity typeother
Related Parties
1- filerCIK 0001351779
Filing Metadata
- Form type
- 4
- Filed
- Feb 10, 7:00 PM ET
- Accepted
- Feb 11, 4:31 PM ET
- Size
- 9.2 KB